4 July 2025 -- Beijing, China -- RealMan Intelligent Technology announced that it is showcasing its latest innovations at Automatica 2025, the world’s leading trade fair for smart automation and robotics.

1 July 2025 -- Cambridge, UK -- 4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field.

30 June 2025 -- Odense, Denmark -- Alphalyse, a fast-growing Danish specialist CRO that has developed GMP‑validated LC‑MS assays for HCP impurity testing in biologic drugs, today announces that Fidelio Capital has acquired a majority stake in the company.

27 June 2025 -- Ravensburg, Germany and Illinois, US -- Vetter, a leading, globally operating Contract Development and Manufacturing Organization (CDMO), celebrated the start of construction for its new clinical manufacturing site in Des Plaines with an official groundbreaking ceremony on June 26.

26 June 2025 -- Virginia, US -- AAPS is excited to announce the opening and closing plenary speakers for the 2025 PharmSci 360, taking place November 9-12, in San Antonio, Texas.

24 June 2025 -- Cambridge, UK -- Enhanc3d Genomics, the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge.

24 June 2025 -- Lausanne, Switzerland and Maryland, US -- Alithea Genomics, a pioneering biotech company based in Switzerland and the USA specializing in high-throughput RNA sequencing solutions, today announced the commercial launch of MERCURIUS™ FLASH-seq, a next-generation library preparation kit for full-length single-cell RNA sequencing.

24 June 2025 -- Cambridge, UK -- OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced it has secured £1.8M in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures.

June 2025 -- Cologne, Germany -- The 38th International Exhibition for Fine and Speciality Chemicals has delivered a resounding success, proving that this industry thrives under pressure. Following a dynamic two-day run at Koelnmesse in Cologne, Germany, the event generated significant impact at a pivotal moment for the global chemicals industry.

19 June 2025 -- Hamburg, Germany and Oss, The Netherlands -- Flindr Therapeutics, a precision oncology company developing first-in-class small molecule inhibitors for cancer, and CrystalsFirst, a leader in structure-based drug discovery and target enablement, today announced a strategic partnership to accelerate target enablement and drug discovery across Flindr’s oncology pipeline.

16 June 2025 -- Minnesota, US -- Ecolab Life Sciences today announced it has launched an innovative new resin to help achieve cost savings and optimize operations throughout the antibody manufacturing process.

18 June 2025 -- Oxford, UK -- Refeyn, the company behind pioneering mass photometry technology, announces that mass photometry has been recognized by the U.S. Pharmacopeia (USP)—and referenced in the new draft USP general chapter <1067>—as a key orthogonal method for characterizing USP’s new adeno-associated virus (AAV) reference standards.